Which pricing innovation by a scientific equipment manufacturer most significantly increased laboratory access to DNA sequencing technology in the early 2010s?

In the competitive scientific equipment marketplace, innovative pricing strategies can make or break a product's success. Companies must balance accessibility with profitability while considering research budgets and institutional purchasing constraints. This poll tests your knowledge of a groundbreaking pricing approach that revolutionized access to essential scientific equipment.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Illumina's introduction of the $1,000 human genome sequencing threshold, dramatically reducing the previous $100,000+ cost barrier
Oxford Nanopore's subscription-based portable sequencer model with no upfront equipment costs
Roche's academic consortium pricing, where multiple institutions shared ownership and operational costs
Thermo Fisher's reagent-as-a-service model, providing free sequencers with long-term consumable contracts